Sharps Technology to acquire InjectEZ syringe manufacturing assets for $35M

Sharps Technology Inc. signed an asset purchase agreement to acquire the InjectEZ specialty syringe manufacturing assets in West Columbia, South Carolina for $35 million. The facility will be the only dedicated COC prefillable syringe manufacturing plant in North America.

“Sharps will strengthen its manufacturing capacity with a $35 million acquisition of assets, establishing the Company's position in the specialized copolymer prefillable syringe (PFS) system industry in the U.S.”biospace.com

• 1 source
• biospace.comSharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S. - BioSpaceAnnalee ArmstrongMay 30, 2024

Summarized from public sources; check the original articles before acting on it.